Dataset Information

Awareness about the relation of noise induced hearing loss and use of headphones at Hail region.

ABSTRACT:

Background

Noise induced hearing loss is the one of the most preventable causes of hearing loss in all age groups. Occupational, environmental, infectious and genetic factors all play a role in determining the level of hearing loss. However, the use of headphones and personal listening devices is now very common, especially in younger generations. Healthy habits are needed to prevent them from developing hearing loss over time. We aim to assess the awareness level of hearing loss among residents of Hail region and its relation to personal listening devices.

Methodology

This is a cross-sectional survey based study that was conducted in 2021 over a duration of four months. The survey purpose was to assess the level of awareness about the Relation of Noise-Induced Hearing Loss and Use of Headphones. The questionnaire had a total of 37 questions which were divided into 6 categories. All data was analyzed using SPSS 21, and a p-value of <0.05 was deemed significant.

Results

The study included a total of 1086 participants. Sampled population age ranged from 18 to 55 years with a mean age of 24.8 ± 12.6 years old. Meanwhile, 636 (58.6%) of the participants were females and 1074 (98.9%) were Saudi. Hearing problems were significantly higher among those who were exposed to noise at work setting than others (26% vs. 15.9%, respectively; P = .001). Duration of the listening session/per day for more than 5 h was significantly associated with higher rates of hearing problems among participants (33.9% vs. 16.5%, respectively = .001). Typical level of TV or radio volume of 90-100 was associated with hearing problems among 32% compared to 11.2% for 0-49% (P = .001).

Conclusion

There is a low awareness level of hearing loss and its causes among the population with more than half of the respondent having unhealthy habits in listening to sounds through their personal devices. Factors related to develop hearing loss included age, volume level and duration of weekly sessions.

SUBMITTER: AlQahtani AS

PROVIDER: S-EPMC8685984 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:Noise-induced hearing loss (NIHL) is a prevalent form of adult hearing impairment, characterized by oxidative damage to auditory sensory hair cells. Although certain dihydropyridines, the L-type calcium channel blockers, exhibit protective properties against such damage, the ability of third-generation dihydropryidines like lercanidipine to mitigate NIHL remains unclear.We utilized glucose oxidase (GO)-treated OC1 cell lines and cochlear explants to evaluate the protective influence of lercanidipine on hair cells. To further investigate its effectiveness, we exposed noise-stimulated mice in vivo and analyzed their hearing thresholds. Additionally, we assessed the antioxidative capabilities of lercanidipine by examining oxidation-related enzyme expression and levels of oxidative stress markers, including 3-nitrotyrosine (3NT) and 4-hydroxynonenal (4HNE). Our findings demonstrate that lercanidipine significantly reduces the adverse impacts of GO on both OC-1 cell viability (0.3 to 2.5 µM) and outer hair cell (OHC) survival in basal turn cochlear explants (7 µM). These results are associated with increased mRNA expression of antioxidant enzyme genes (HO-1, SOD1/2, and Txnrd1), along with decreased expression of oxidase genes (COX-2, iNOS). Crucially, lercanidipine administration prior to, and following, noise exposure effectively ameliorates NIHL, as evidenced by lowered hearing thresholds and preserved OHC populations in the basal turn, 14 days post-noise stimulation at 110 dB SPL. Moreover, our observations indicate that lercanidipine's antioxidative action persists even three days after simultaneous drug and noise treatments, based on 3-nitrotyrosine and 4-hydroxynonenal immunostaining in the basal turn. Based on these findings, we propose that lercanidipine has the capacity to alleviate NIHL and safeguard OHC survival in the basal turn, potentially via its antioxidative mechanism. These results suggest that lercanidipine holds promise as a clinically viable option for preventing NIHL in affected individuals.